CN Healthy Food Tech Group Corp.: Nasdaq panel approves continued listing

What happened On Oct 7, 2026, the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC issued a decision finding CN Healthy Food Tech Group Corp. in compliance with the Nasdaq listing rules and granting the Company’s request to remain listed on Nasdaq, subject to conditions including a one-year Discretionary Panel Monitor. The Panel also found the Company failed to provide Nasdaq and the public with accurate information about the status of its application with the China Securities Regulatory Commission, but that the omission did not relate to the Company’s finances or business operations. The Company filed this Current Report on Form 8-K on Oct 13, 2026 to satisfy the Panel’s public disclosure condition.

Key details

• Nasdaq Staff notified the Company of a delisting determination in a letter previously disclosed on Jul 21, 2026; the Panel hearing was held on Aug 27, 2026 and the Panel Decision issued on Oct 7, 2026; the Staff’s determination related to the Company’s Form 8-K filed Sep 30, 2025.
• The Panel required public disclosure by Oct 14, 2026 and imposed remedial measures that the Company implemented and committed to maintain for a period of three years, including: terminating prior PRC counsel and engaging a new PRC law firm under a three-year engagement as a compliance advisor; adopting a Rectification Measures Outline (establishing a Compliance and Risk Management Department, regular compliance self-assessments, internal compliance training, and a Disclosures & Communications Committee); implementing a multi-level review process and formal disclosure controls and procedures; and maintaining a seven-member board with three executive directors and four independent directors with fully independent audit, compensation and nominating and corporate governance committees.
• The Panel imposed a one-year Discretionary Panel Monitor pursuant to Nasdaq Listing Rule 5815(d)(4)(A); if the Company fails any listing standard during the monitoring period, the Listing Qualifications Department will issue a Staff Delisting Determination without permitting a plan of compliance or cure period. The Company may request review by the Nasdaq Listing and Hearing Review Council within 15 days but does not intend to do so.
• The filing includes forward-looking statements about resumption of trading, maintaining remedial measures and meeting Nasdaq standards, including minimum market value of publicly held shares and minimum bid price.

Why it may matter This item is reported under Item 3.01 (notice of delisting or failure to satisfy a continued listing rule or standard), which covers Nasdaq’s review of the Company’s listing status and the conditions the Panel imposed to allow continued listing. This filing does not show why the insider traded or why the company acted.